IULIANO, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 78
AS - Asia 43
EU - Europa 22
SA - Sud America 21
Totale 164
Nazione #
US - Stati Uniti d'America 76
SG - Singapore 20
BR - Brasile 16
CN - Cina 6
GB - Regno Unito 6
DE - Germania 4
VN - Vietnam 4
EC - Ecuador 3
FI - Finlandia 3
ID - Indonesia 3
IN - India 3
AT - Austria 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
IT - Italia 2
SE - Svezia 2
TR - Turchia 2
AR - Argentina 1
BD - Bangladesh 1
CA - Canada 1
GT - Guatemala 1
NP - Nepal 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
Totale 164
Città #
Chandler 13
Singapore 12
The Dalles 8
Ashburn 7
Dallas 6
San Jose 6
Chicago 5
Munich 4
Bengaluru 3
Hefei 3
London 3
Santa Clara 3
Baku 2
Brighton 2
Jakarta 2
Lawrence 2
Olomouc 2
Princeton 2
Sumaré 2
Turku 2
Alegrete 1
Ambato 1
Americana 1
Ankara 1
Asunción 1
Bauru 1
Bay City 1
Birigui 1
Boardman 1
Boston 1
Brasília 1
Cradley Heath 1
Córdoba 1
Des Moines 1
Dhaka 1
Florianópolis 1
Guatemala City 1
Hanoi 1
Helsinki 1
Ho Chi Minh City 1
João Monlevade 1
Kathmandu 1
La Concordia 1
Lahore 1
Limeira 1
Los Angeles 1
Lộc Hà 1
Milan 1
Mountain View 1
Nova Iguaçu 1
Pesqueira 1
Piracicaba 1
Quito 1
Recife 1
San Francisco 1
Squillace 1
Stockholm 1
São Paulo 1
Thái Bình 1
Águas de Lindóia 1
Totale 129
Nome #
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 66
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 63
Myositis/myasthenia after pembrolizumab in a bladder cancer patient with an autoimmunity-associated HLA: Immune–biological evaluation and case report 38
Totale 167
Categoria #
all - tutte 1.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 1 0 0 0 1 1 0 1 0
2022/202326 4 3 2 1 5 4 0 3 2 1 1 0
2023/202421 5 4 3 0 0 5 0 0 0 1 1 2
2024/202541 4 1 0 1 1 6 0 0 0 0 17 11
2025/202674 10 11 14 18 7 7 7 0 0 0 0 0
Totale 167